Cell Culture Improvements
US-2015087024-A1 · Mar 26, 2015 · US
US10280217B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10280217-B2 |
| Application number | US-201715708389-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 19, 2017 |
| Priority date | Sep 19, 2017 |
| Publication date | May 7, 2019 |
| Grant date | May 7, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a method of increasing protein biomolecule production in which a) a cell that produces a heterologous protein biomolecule is cultured, and b) an Additive and/or a source of the Additive is added to the culture medium in an amount sufficient to (i) increase a total yield of the heterologous protein biomolecule secreted into the cell culture media and/or (ii) increase a specific cellular productivity of the heterologous protein biomolecule secreted into the cell culture media.
Opening claim text (preview).
What is claimed is: 1. A method of increasing protein biomolecule production comprising the steps of: a) culturing a cell that produces a protein biomolecule, b) supplying an Additive and/or a source of the Additive to the culture medium in an amount sufficient to (i) increase a total yield of the protein biomolecule secreted into the cell culture media and/or (ii) increase a specific cellular productivity of the protein biomolecule secreted into the cell culture media, c) wherein the increase of step b) is measured relative to: culturing under a prior set of conditions established for a regulatory approval for producing the protein biomolecule and/or culturing under substantially the same conditions except for supplying the Additive and/or a source of the Additive, wherein (a) the Additive is Nitric Oxide and/or a chemical source of Nitric Oxide, (b) the cell is a eukaryotic cell, and (c) the protein biomolecule is a heterologous protein biomolecule. 2. The method of claim 1 , wherein the eukaryotic cell is a Chinese hamster ovary (CHO) cell and the heterologous protein biomolecule is a monoclonal antibody. 3. The method of claim 1 , wherein the Nitric Oxide is gaseous and is substituted for a portion of a volume of another gas being fed into the bioreactor. 4. The method of claim 3 , wherein the other gas being fed into the bioreactor includes Oxygen gas, Nitrogen gas and/or or Carbon Dioxide gas. 5. The method of claim 1 , wherein the Nitric Oxide and/or the chemical source of Nitric Oxide are added in an amount sufficient to increase a total yield of the monoclonal antibody secreted into the cell culture media. 6. The method of claim 1 , wherein the Nitric Oxide and/or the chemical source of Nitric Oxide are added in an amount sufficient to increase a specific cellular productivity of the monoclonal antibody secreted into the cell culture media. 7. The method of claim 1 , wherein the Nitric Oxide soluble in the cell culture medium is at a concentration of 0.1-10 nanomolar. 8. The method of claim 7 , wherein the Nitric Oxide is supplied to the cell culture medium as a sparged gas at a concentration of 200-400 ppm Nitric Oxide in the sparged gas. 9. The method of claim 1 , wherein the eukaryotic cell is a CHO cell and the heterologous protein biomolecule is a monoclonal antibody. 10. A cell culture medium comprising: a) a eukaryotic cell line that is capable of secreting a heterologous protein biomolecule, and b) an Additive capable of causing an increase in the amount of heterologous protein biomolecule secreted by the eukaryotic cell, wherein the Additive is selected from one or both of Nitric Oxide gas mixed with the cell culture medium and Nitric Oxide dissolved in the cell culture medium. 11. The cell culture medium of claim 10 , wherein (a) the Additive is Nitric Oxide, (b) the eukaryotic cell line is a CHO cell line, and (c) the heterologous protein biomolecule is a monoclonal antibody. 12. The method of claim 11 , wherein the Nitric Oxide soluble in the cell culture medium is within a concentration range of 0.1-10 nanomolar of Nitric Oxide. 13. A method of screening for a cell line that secretes a heterologous protein biomolecule and which is responsive to an Additive to result in an increased amount of secreted protein biomolecule, the method comprising the steps of: a) establishing a cell culture of the cell line that secretes the heterologous protein biomolecule, b) adding the Additive to the cell culture, c) measuring an amount of the secreted heterologous protein biomolecule protein biomolecule, and d) comparing the amount measured in step c) with an amount of secreted heterologous protein biomolecule representing a control condition lacking the addition of the Additive, wherein the Additive is selected from one or both of Nitric Oxide gas and a chemical capable of forming Nitric Oxide. 14. The method of claim 13 , wherein (a) the Additive is selected from one or more of Nitric Oxide gas and a chemical capable of forming Nitric Oxide, (b) the cell line is a CHO cell line, and (c) the heterologous protein biomolecule is a monoclonal antibody.
Glycosylation, sialylation, or fucosylation · CPC title
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value · CPC title
Cells for large scale production · CPC title
Atmosphere, e.g. low oxygen conditions · CPC title
Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound (C12N1/34 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.